..

A Comparison of Quantum Research, Inc.’s Special Bovine Colostrum/Whey Extract to Other Colostrum and Whey Products

Quantum Research formulations have been shown in clinical studies to dramatically and consistently increase natural killer (NK) cell activity. Research indicates that increasing NK cell activity is a tremendous benefit for the restoration and maintenance of health. No other colostrum and whey products can make the NK cell function claim based on clinical studies.

ABBREVIATIONS: NK; Natural Killer Cell

Acute low NK cell activity resulting from temporary stress can be eliminated with the elimination of the stress factor. For example, if we are over-tired and under-nourished, we can simply rest and eat properly for a few days and recover. However, when we become continually immune compromised we start developing recurring problems which may lead to serious or chronic conditions.

Specific intervention can be necessary to rebuild the immune system in the face of serious or chronic conditions if recovery is to occur. At a certain point, rest and general nutrition are just not enough. This is when most people turn to pharmaceutical products for recovery and symptomatic relief. Unfortunately, this has not been a viable approach, as drugs do not address the deficiencies that are necessary for real and lasting recovery. Drugs do not build up the immune system and often produce a weakening in the long run. The lack of results and the many side effects of drugs have caused millions to turn to alternative approaches for their health recovery.

There are numerous nutritional substances that support the immune system when taken in sufficient quantities and combinations. Vitamin A, vitamin C and vitamin E, zinc, calcium, goldenseal and echinacea, are just a few of the vitamins minerals and herbs that support the immune system. Vitamin C and vitamin E will increase NK cell activity slightly, but not dramatically nor consistently. In fact, the search for a safe and effective strategy to enhance NK cell activity and accordingly, provide effective immune system support has been in progress for several years.

Dr. Stanley R. Olsztyn, a medical doctor specializing in alternative medicine, has been developing such products since the 1970’s. He has been working with and developing special colostrum/whey extracts in combination with herbs, vitamins and other nutritionals. Dr. Olsztyn discovered that colostrum/whey extracts with synergistic nutritional components did, in fact, increase NK cell activity both dramatically and consistently. This explained why the thousands of patients to whom he had given his formulas responded so well and so quickly. In 1993, after 15 years of clinical research and development, he introduced his results to the general public.

Concurrently, Dr. Jesse A. Stoff, a prominent viro-immunologist and researcher, was exploring ways to expand his protocol for immune system support. He conducted extensive laboratory evaluation on his patients in his Tucson clinic and was searching for a "transfer factor" substance that he reasoned would dramatically enhance the immune system. Dr. Stoff became aware of Dr. Olsztyn’s formulas and began evaluating them in his practice. As Dr. Stoff deals primarily with severe and chronic cases, it was a perfect setting to evaluate the Olsztyn products under the most rigid clinical conditions.

Dr. Stoff published the results of his findings using Dr. Olsztyn’s special extract of colostrum and whey in combination with other nutritional factors. The study is most impressive, showing patient response following dramatic increases in their NK cell activity. Recovery and remission from many of the most serious of health problems of this time were documented.

Due to the success of the clinical studies, Dr. Stoff has joined Dr. Olsztyn for continuing research and the development of new products using the special colostrum/whey extract and an array of natural substances. Matol Biomune OSF Plus™ is the first of these new products.

.

CLINICAL STUDY

THE USE OF DIALYZABLE BOVINE COLOSTRUM
EXTRACT IN CONJUNCTION WITH A HOLISTIC
TREATMENT MODEL FOR NATURAL KILLER CELL
STIMULATION IN CHRONIC ILLNESS

THE USE OF DIALYZABLE BOVINE COLOSTRUM EXTRACT IN CONJUNCTION WITH A HOLISTIC TREATMENT MODEL FOR NATURAL KILLER CELL STIMULATION IN CHRONIC ILLNESS
By: Jesse A. Stoff, MD, MFHOM, FACLM

A longitudinal evaluation of the natural killer cell (NK activity) of peripheral blood lymphocytes was performed in 107 patients with documented and advanced chronic illness and followed for an average period of 13.2 months. At the time of primary evaluation and treatment, the absolute value of natural killer cell activity was significantly lower than the normal range. Hence, the association of chronic illness with the syndrome of low natural killer cell activity.

During the follow-up period, a variety of nutritional agents were given to support natural killer cell function and then dialyzable bovine colostrum extract was added to the protocol. In the ensuing months, the curve of NK cell reactivation into normal ranges and above was monitored as immune system competence was restored.

The use of natural immunomodulators including the use of dialyzable bovine colostrum extract can be concluded as a viable therapeuticum in NK cell reactivation in the face of chronic illness.

Doctor's Notes Patient outcome discussion

Patient No. Patient Age Condition Month Treated Initial NK Level Last NK Level Comments on Outcome 144 48 CFS, Psoriasis 20 21 780 Back to work, skin improving, high energy 145 50 Colon Polyps 26 1 174 Cured 149 48 Adenocarcinoma 22 1 1030 Remission 150 77 Prostate Cancer 21 7 657 Remission 151 49 Hep C 27 3 390 Remission 152 36 CFS 22 12 380 Feeling well and back to work 153 39 CFS, EBV, Staph 27 8 365 Healthy 154 62 Prostate Cancer 22 3 90 Remission 155 66 Carcinoma 10 4 830 Remission 156 57 Carcinoma 11 9 415 Remission 157 42 Ovarian Cancer 15 23 148 Remission 158 78 Prostate Cancer 3 3 419 Remission 159 50 AIDS 36 1 330 Opportunistic infections ceased 160 61 CFS 25 0 204 Feeling good, near recovery 161 62 Colon Cancer 17 45 466 Stabilized 162 43 Severe Allergies 30 22 315 Resolved 163 56 CFS 23 20 225 Resolved 164 44 CFS & others 24 1 273 Resolved 165 56 CFS 16 26 399 Resolved 166 48 CFS 14 4 172 Resolved 167 41 Bladder Cancer 13 2 148 Resolved 168 76 Prostate Cancer 19 3 92 Remission 169 50 HSV-II 18 6 282 Remission 170 47 CFS, Colon Polyps 20 3 189 Much improved 171 49 CFS 23 1 266 Steadily improving 172 46 Ductal Carcinoma 13 11 179 Remission 173 60 CMV 38 4 297 Cured 174 72 Lymphocytic Leukemia 24 1 89 Stabilized & improved 175 36 CFIDS, HHV-6 59 18 315 Resolved 176 37 Autoimmune Dysfunction 29 1 623 Normal 177 41 Myelodysplasia 9 8 349 Normalized 178 82 Lymphoma (Non Hodgkin) 16 26 634 Stable & progressing 179 58 Lymphocytic Leukemia 39 0 730 Stable & dormant 180 38 Chronic Infection 31 4 368 Normalized 181 36 Colitis, Allergy 36 38 550 Normalized 182 55 B-cell Leukemia 14 5 210 Stable & improving 183 66 Colitis 16 17 125 Much improved 184 65 Prostate Cancer 13 21 367 Stable, good prognosis 185 33 EBV 29 1 295 Full remission 186 41 Thyroditis 20 2 230 Much improved & improving 187 53 CFS 17 16 345 Improving rapidly 188 53 Myelodysplasia 10 5 249 Improving rapidly 189 64 Prostate Cancer 19 14 845 Asymptomatic 190 65 CFIDS, Allergies 23 14 398 Back to work 191 30 Basal Cell Carcinoma 29 51 140 Resolved & remission 192 53 Breast Cancer 22 105 845 Disease free 193 76 Lung Cancer 9 25 88 Stabilized & resolving 194 55 Colon Cancer 12 40 72 Obstruction resolved & asymptomatic 195 59 CFS 5 11 21 Returned to active life, feeling good 196 58 Breast Cancer 8 11 31 Recovering well 198 65 Prostate Cancer 1 2 38 Full remission 199 56 CFS 11 20 127 Energetic & returned to active life 200 62 Colon Cancer 1 45 219 Resolved 201 48 CFS 6 12 101 Recovered & "feels like a new woman" 202 47 Crevical Cancer 4 1 46 Cancer, Herpes & Genital Warts in remission 203 49 Colon Cancer 8 3 49 Remission 204 51 CFS 19 21 780 Returned to active life 205 36 CFS, Lupus 16 7 28 Remission, back to graduate school 206 40 CFS 13 42 185 Recovered 207 48 Ovarian Cancer 12 79 399 Resolved 208 40 CFS 13 17 56 Returned to active life 209 43 Bladder Cancer 15 2 164 Remission 210 67 Prostate Cancer 2 5 103 Remission 211 66 Prostate Cancer 11 14 608 Remission, back to active life 212 50 Parotid Cancer 5 29 142 Remission, back to active life 213 79 Prostate Cancer 20 7 499 Remission 214 54 Breast Cancer 9 47 436 Remission 215 64 CFS 3 0 69 "Spunky again" 216 56 CFS 13 2 41 Full recovery 217 49 Lupus 9 8 38 Remission 218 63 Leukemia 5 117 376 Improving significantly 219 47 Breast Cancer 5 33 689 Avoided surgery, back to normal life 220 70 COPD, CFS 15 1 73 CFS resolved, back to spry grandma 221 53 Breast Cancer, Thyroiditis 10 132 255 Thyroid corrected, cancer remission 222 50 EBV 8 15 28 Doing well, feels alive again 223 44 Ovarian Cancer 3 23 70 Remission 224 39 EBV, Lupus 7 19 66 EBV remission, Lupus has disappeared 225 52 Prostate Cancer 2 5 39 Full remission 226 84 Lymphoma 4 26 69 Full recovery 227 49 Appendix Adenocarcinoma 10 18 56 Full remission 228 50 CFS 3 4 44 Feeling great again 229 77 Cancer 8 82 348 Remission 230 55 CFS 5 18 50 Resolved, returned to career 231 21 EBV, Severe Herpes Stomatitis 14 5 32 Resolved 232 49 Leukemia 0 2 11 Remission 233 57 CFS 8 13 40 Really well, full remission 234 52 CFS 5 2 22 Improving steadily 235 66 Renal Carcinoma 7 3 11 Remission 236 55 Lupus 13 1 15 Recovering well, slowly resolving 237 78 Prostate Cancer 6 3 19 Heavy chemo slowed healing, now in remission 238 40 CFS 15 100 169 Full recovery 239 48 Breast Cancer 4 3 38 Remission 240 31 CFS 1 12 86 Full remission 241 65 Prostate Cancer 1 18 287 Full remission 242 17 Acute Mono 2 0 79 Full recovery very fast 243 46 Ovarian Cancer 1 15 118 Full remission 244 38 Breast Cancer 2 3 218 No sign of disease 245 53 Lung Cancer 2 9 198 Improving significantly 246 68 Colon Cancer 2 36 246 Fully recovered 247 47 Cervical Cancer 2 20 182 Remission 248 31 CFS 2 7 68 Remission in 4 months 249 29 CFS 2 14 92 After 8 years illness, 4 months 90% of old self 250 62 Lymphoma 1 27 68 Tumor decreasing 251 73 Myeloma 2 4 148 Fully recovered 252 26 CFS 2 30 87 Full remission 253 43 Breast Cancer 1 17 289 Improving very nicely 254 58 Myelofibrosis 2 1 79 Making great progress

The marvelous array of deftly interacting cells that defend our body against invaders, arise from a few precursor cells that first appear at about 9 weeks after conception. From that point on, the cells of the immune system go through a continuously repeated cycle of growth and development and become fully competent at around 6 months of age after our birth.

The parent cells of our immune system are referred to as stem cells. These are the cells upon which the immune system depends to both reproduce itself and gives rise to the many specialized lineage's that spring from it; the B cells, macrophages, natural killer (NK) cells, helper T cells, etc.

The cells of the immune system are not isolated in a single body space or arranged in the form of a single organ. Instead, the majority of them exist as potentially mobile entities unattached to other cells. This characteristic is crucial to their function. Every minute of every day, war is waged within our body. The combatants are too small to see. Some, like the infamous HIV virus, are so small that 230 million would fit on the period at the end of this sentence. Yet, they employ tactics that can vanquish the much larger cells upon which our immune system is based. Usually, we never even notice the battles within us.

We have evolved legions of defenders, specialized cells that silently destroy the unseen enemy. Sometimes these warriors mistake harmless invaders such as pollen for deadly foes and trigger an allergic response. Occasionally, some of our own cells begin the mutinous uncontrolled proliferation characteristic of cancer and manage to evade the surveillance of our body's defensive forces. For every successful penetration of our defenses, millions of attempts are repelled. We sleep securely at night trusting the invisible vigilantes of our immune system.

The science and practice of immunology traces back to 1721 to Lady Mary Wortley Montagu. She introduced England to a Turkish process of inoculation with unmodified smallpox virus in an attempt to stem the ravages of the normal course of the disease. Her techniques were quite crude and as many as her patients died as survived but those that survived were immune to the disease forever more.

Over the decades and centuries, scores of doctors and researchers honed the art of immunology into a more and more refined science. Many of the wonderful blood tests that we have today and information that we now know about immunology was unknown to us a scant 20 years ago. Information on the science of immunology doubles at the rate of approximately every 5 to 6 years. So, we must remember that the wonderful ways that we have today to support and direct the immune system to help protect us and fight off illnesses is a mere foreshadow of things to come in the (near) future

Our immune system is a miracle of evolution. There is interesting research to suggest that elements of our immune system were, at one time, actually independent organisms. They were incorporated into our body, millions and millions of years ago, as a type of symbiotic mutually beneficial relationship. Our immune system is not controlled by any central organ such as the relationship of our brain to our nervous system. Rather, it has developed and functions as a kind of biological democracy where the individual members achieve their ends through an information network of biochemical substances called, "cytokines".

Many different variables in our environment and lifestyle can effect the efficiency of its function. Our immune system accounts for approximately 1% of our body's 100 trillion cells. These defender cells originally arise in our bone marrow and mature in other parts of our body, the thymus, spleen and lymph glands. The different lineage's which develop all share one common objective; to identify and destroy all substances, living or inert, that are recognized as foreign to our body. This includes cancer cells that challenge our immune system everyday for each and every one of us.

NK cells were discovered in the 1970's and constitute up to 15% of the total lymphocyte population in normal healthy subjects. They are capable of killing a broad range of tumor and virus infected cells. Depressed NK cell activity and depressed NK cell populations are associated with the development and rapid progression of cancer, hepatitis, AIDS, Chronic Fatigue Syndrome, various immunodeficiency syndromes, and certain autoimmune diseases. In my practice I almost exclusively work with people with severe and chronic diseases, that are known to present abnormally low levels of NK cell function.

NK cells now appear to present the first line of defense against metastatic spread of tumors. In numerous studies, low NK cell populations were correlated with greater and more rapid spread of tumors with shorter host longevity and with greater morbidity.

There are four critical phases to the immunological response and lifestyle issues and some dietary supplements can influence them.

During phase one, the offending invader is identified and recognized as being foreign to our body and then quickly consumed by hungry roving macrophages. You can think of macrophages as little PAC men that are found in all of the tissues in our body and circulating around in our blood stream looking for their next free lunch. They seize upon this foreign agent, engulf it, eat it and release a series of cytokines that then trigger the 2nd phase of the immunological reaction.

Immune-modulation is a new and key step in supporting immune function. This can include a number of different substances, depending upon the situation, including: transfer factor (obtained in specially prepared colostrum/whey extracts), Astragalus, Arabinogalactan, Viscum extracts, vitamin C, iodine, lactoferrin, certain amino acids, neurotransmitter hormones and the prohormone DHEA.

In the study group, generic NK cell response was monitored using transfer factor, obtained in specially prepared colostrum/whey extracts, along with the herb Astragalus that is known to accelerate and support immunological reactions. The transfer factor component was produced from cows that have been immunologically stimulated using a patented process. This process does not hurt the cow. In fact, it stimulates the cow’s immune system for its own protection.

When a cow gives birth to a calf, the first flow of milk is called the colostrum. The colostrum is collected and the transfer factor molecules are extracted. At appropriate opportunities, collection can also occur from the milk following colostrum. This is generally referred to as whey. Since none of the milk proteins remain, these products are safe even for people with a dairy allergy. The purified transfer factor can then be given to people to passively stimulate their NK cells function to alert-activity status, thus protecting them to a significant degree from illness as well as helping them recover from illness.

Lifestyle issues that will affect the functioning of our immune system include exposure to toxins (heavy metals, petrochemicals, radiation, etc.) and dietary and nutritional deficiencies that can rob the immune system of the biochemical foundation that it relies upon in order to function normally. Another major lifestyle issue relative to immune function is stress.

The use of other nutritional support factors in conjunction with the dialyzable colostrum/whey extract and astragalus was important for patient recovery. However, I want to point out three significant factors in relation to that fact:

Most of the patients were advanced in their conditions and had tried other approaches for their health recovery before I saw them in my clinic.

The dialyzable colostrum/whey extract was critical to their recovery. Without that component, providing the transfer factors discussed herein, many of the patients simply would not have recovered.

I have utilized a wide array of well-known and privately prepared colostrum products with disappointing results. These products were not helpful to my patients as they failed to significantly increase NK cell function or consistently provide any other significant immunological benefits that could be measured.

I also observed that people who were not severely compromised responded well to daily supplementation of the colostrum/whey extract and astragalus without additional nutritional supplementation. Even though adequate nutritional support is important it was noted that the extract of dialyzable colostrum/whey and astragalus is very powerful and valuable in combination without additional supplementation.

With any health problem, it is much more prudent and efficient to prevent disease by maintaining a high level of immune function. Research has shown that low NK cell activity is present nearly all illness. A daily dietary regimen that includes dialyzable bovine colostrum/whey extract has been shown to significantly help maintain high NK cell activity and thereby dramatically increase the ability of the immune system to maintain a healthy condition.

Conclusions:

This Study Group demonstrates that stimulation of NK activity paralleled restored resistance to illness and recovery from illness. NK cell activity is correlated with disease status in those patients with hematologic malignancy such as leukemia and lymphomas as well. In some studies, on patients with leukemia, a sudden and maintained decrease in NK cell activity was reported nearly always to proceed relapse, even if the patient had been in complete remission for some time. This also correlated with a general drop in the percentage of lymphocytes as measured in a standard blood test. NK cell function is a well-regulated activity subject to both inhibitory and excitatory control.

2. Transfer factor is effective across different mammalian species.
"Isolation and purification of HSV-1 specific transfer factor produced by
HSV-1 immunized goat leukocyte dialysate" by Dr. Qitly et al, Acta Virol
1992, May; 36(3): 231-8

3. Transfer factor is just as effective when taken orally as by injection.
"Murine transfer factors: dose-response relationships and routes of
administration" Kirk Patrick, C.H., et al, Cell Immunol, 1995, Sep; 164(2):
203-6

4. "Transfer factor presents relapse in herpes keratitis patients; a pilot study"
Pizza, G. et al, Biotherapy 1994; 8(1): 63-8

5. "Adjuvant treatment using transfer factor for bronchogenic carcinoma: long- term follow-up", Whyte, R.I. et al, Arr Thoracic Surgery, 1992, Mar; 53(3): 391-6

6. "Immunotherapy with transfer factor of recurrent herpes simplex type I", Estranda-Parra, S. et al, Arch Med Res, 1995;26

7. "Effect of Brucella abortus transfer factor in preventing murine brucellosis", Stevens, M.G. et al, Immunol Med Microbiol, 1995, Jul; 11(4): 279-84

8. "Transfer factor in malignancy", Pizza, G. et al, Prog Drug Res 1994; 42: 401-21

9. "Specific transfer factor with activity against Epstein-Barr virus reduces late
relapse in endemic Burkitt’s lymphoma", Neequaye, J. et al, Anticancer
Research 1990 Sept-Oct; 10 (5A): 1183-7

10. "A controlled trial of bovine dialyzable lukocyte extract (transfer factor) for
cryptosporidiosis in patients with AIDS" McMeeking, A. et al, J. Infect Dis,
1990 Jan; 161(1): 108-12

11. Clark D, Wyatt K: Colostrum, Life’s First Food. Salt Lake City: CNR
Publications, 1996.

12. Lange S: Immune mechanisms of cardiac disease. New England Journal
Of Medicine 330(7): 1129, April 21, 1994.

13. Kohl S, et al: Human colostral cytotoxicity: antibody-dependent cellular
cytotoxicity against herpes simplex infected cells mediated by colostral
cells. Journal of Clinical Laboratory Immunology 1:221-224.

14. Acosta-Altamirano G, et al: Anti-amoebic properties of human colostrum.
Adv Exp Med Biol 216B: 1347-1352, 1987.

15. Boesman-Finkelstein M., et al: Passive oral immunization of children. The
Lancet. 49:1336, 1989.

16. Haynes BF, Fauci AS: Introduction to clinical immunology. Part II,
section 2. in: Harrison’s Principles of Internal Medicine, Eleventh Edition. Braunwald E (eds), et al. New York: McGraw Hill Book Co, Janusz M, et al: Immunoregulatory properties of synthetic peptides:
fragments of a proline-rich polypeptide from bovine colostrum.
Molecular Immunology 24(10): 1029-1031, 1987.

17. Kim K, et al: In vitro and in vivo neutralizing activity of human colostrum and milk against purified toxins A and B of Clostridium difficile. T Infect Dis 150:57-61, 1985.

18. Ogra P, et al: Colostrum derived immunity and maternal neonatal
interaction. Annals NY Acad Sci 409:82-92, 1983.

19. Palmer EL, et al: Antiviral activity of colostrum and serum immuno- globulins A and G. J Med Virol 5:123-129, 1980.

20. Sabirl, AB: Anti-poliomyelitic substance in milk from human beings and certain cows. T Dis Children 80:866-870, 1950.

21. Spik, G., et al., Bacteriostasis of a milk-sensitive strain of E. coli by immuno-
globulins and iron-binding proteins associated with colostrum. Immunology 35:663-670, 1981.

22. Stephan W, et al: Antibodies from colostrum in oral immunotherapy.
J Clin Chem Clin Biochem 28:19-23,1990.

23. Wada N, et al: Neutralizing activity against Clostridium difficile toxins in the
supernatants of cultured colostral cells. Infect Immune 29:545-550,1980.

24. Ferrer-Argote VE; Romero-Cabello R; Hernandez-Mendoza L; Arista-
Viveros A; and others Successful treatment of severe complicated measles with non-specific transfer factor. Department of Hematology, Hospital General de Mexico, DF, Mexico. In Vivo 1994 Jul-Aug; 8 (4): 555-7

25. Rebulla P; Tedesco F; Radillo O; Battaglioli M; and others Inhibition of in vitro adherence of antibody-coated red cells to monocytes by the dialyzable leukocyte extract. Centro Trasfusionale e di Immunologia dei Trapianti, Ospedale Policlinico, Milan, Italy. Transfusion 1991 Mar-Apr; 31 (3): 218-21

26. Fazio M; Negri L; Calabrese F; Correggia F; and others A new method for the in vitro transfer of delayed hypersensitivity by dialysed transfer factor. J Nucl Med Allied Sci 1990 Oct-Dec; 34 (4 Suppl): 271-4

27. Fazio M; Calabrese F; Giacomasso S; Meina G; and other Transfer in vivo of tuberculin hypersensitivity by sensitized lymphocytes. Chair of Medical Oncology, University of Turin, Italy. Panminerva Med 1993 Sep; 35(3): 149-53

28. Mrazova A; Mraz J Transfer factor and its signification for practice. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove 1993; 36(3): 117-37

29. Sumiyama K; Kobayashi M; Miyashiro E; Koike M Combination therapy with transfer factor and high dose stronger neo-minophagen C in chronic hepatitis B in children (HBe Ag positive). Department of Pediatrics, Wakayama Medical College, Japan. Acta Paediatr Jpn 1991 Jun; 33(3): 327-34

30. Snirc J; Mikula I; Pistl J The induction of specific protection against Actinobacillus pleuropneumoniae infection by specific DLE. Department of Microbiology and Immunology, University of Veterinary Medicine, Kosice, Slovakia. Acta Microbiol Hung 1993; 40(4): 325-33

31. Qi HY; Wan ZF; Su CZ Isolation and purification of HSV-1 specific transfer factor produced by HSV-1 immunized goat leukocyte dialysate. Department of Biochemistry, Fourth Military Medical University, Xian, P.R. China. Acta Virol 1992 May; 36(3): 231-8

32. Fernandez O; Diaz N; Morales E; Toledo J; and others Effect of transfer factor on myelosuppression and related morbidity induced by chemotherapy in acute leukaemias. Hospital Universitario Dr. Carlos J. Finlay, Marianao, Cuba. Br J Haematol 1993 Jul; 84(3): 423-7

33. Kirkpatrick CH Structural nature and functions of transfer factors. Conrad D. Stephenson Laboratory for Research in Immunology, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206.

REVIEW ARTICLE: 26 REFS.
Ann N Y Acad Sci 1993 Jun 23; 685: 362-8

Study Group Profile

Cancer 50%

Including Lupus, Allergies, Fibromyalgia, Blood Disorders, Chronic Infections,

All Study Group participants recorded significantly higher NK cell activity.

2-8 per day. 20.

GRAPHIC ILLUSTRATION OF CLINICAL STUDY

Biomune OSF Plus™

The potential benefits available through colostrum and whey are being discussed everywhere. Claims of benefit from the consumption of "Pure, Clean Colostrum" or "Filtered Whey" are everywhere. Indeed, the benefit of breast-feeding infants has covered magazine racks for years.

Bovine colostum is touted as the "new" source of health. Bovine colostrum is now a commodity. Buyers and sellers from all over the world are being brought together for the purpose of creating a new marketable commodity. New companies have emerged to sell this commodity in various forms of "after-market" marketing.

Though bovine colostrum has some demonstrated benefit, by itself bovine colostrum is not a silver bullet. It is simply another commodity like wheat or milk. As with all commodities, all are not created equal and do not contain equal characteristics. Quantum Research, Inc. and Dr. Jesse Stoff have demonstrated that high quality, highly controlled extracts can be combined with other nutritional ingredients to create significant products that can bring changes in the performance of the immune system.

Quantum Research, Inc. is able to create the amazing extracts used in the products for several reasons.

They use a proprietary technology, protected by a totally unique and protected patented process.

They utilize a privately managed dairy herd that originated over thirty years ago.

They access nearly forty years of experience in bovine colostrum collection and study.

Dr. Stoff and/or Dr. Olsztyn have used these extracts for over twenty years in medical practice.

Biomune OSF Plus™ utilizes the herb astragalus in combination with a special extract of dairy colostrum and whey. Clinical studies indicate that this combination creates a synergistic effect on the immune system resulting in elevation of NK cell activity.*

Active ingredients contained in astragalus include bioflavanoids, choline, and astragalan B, a polysaccharide. Astragalan B has been shown in animal studies to be effective at protecting the body against a number of toxins, controlling bacterial infections and stimulating the immune system. Astragalan B appears to work by allowing the body’s immune system to attack the outer membranes of viruses, destabilizing their defenses and allowing them to be overwhelmed by the immune response.

Astragalus increases interferon production and enhances NK and T cell function, increasing resistance to viral conditions. Astragalus has also been shown to support the body in peripheral vascular disease and peripheral circulation. Astragalus aids adrenal gland function that often needs support in chronic and degenerative health states.

Researchers in China have conducted recent studies which report that Astragalus is an effective treatment for supporting the immune system in cancer patients. Two separate studies followed patients receiving traditional chemotherapy and radiation treatment, which typically devastate the immune system and leave the recipients weak and susceptible to new opportunistic infections. Patients receiving astragalus extracts had twice the survival rate of those only receiving standard therapies. Further studies in the U.S. confirmed that Astragalus has unique immunity enhancement qualities.

Astragalus has been available China for centuries and has a long history of use in traditional medicine in China. It is used to strengthen the Wei Ch’i or "denfensive energy". It is regarded as a tonic for stimulating the immune system and increasing energy levels. It has also been used as a diuretic and a vasodilator for respiratory infections. It has also been used for colds, flu and to increase stamina.

Ingredients: BIOMUNE OSF™ Plus
	Bovine colostrum/whey extract (Ai/E10®)
	Astragalus (root).